AMIVIB 500 INJECTION (DPCO)AMIKACIN 500mg. IP

Amivib 500 Injection is used for the short-term treatment of serious infections caused by susceptible Gram-negative bacteria. Main uses: short-term treatment of serious infections due to susceptible Gram-negative bacteria (Pseudomonas, E. coli, Proteus, Providencia, Klebsiella-Enterobacter-Serratia, Acinetobacter); bacterial septicemia (blood infection), including neonatal sepsis; serious infections of the respiratory tract, bones and joints, skin and soft tissue; infections of the central nervous system, including meningitis; intra-abdominal infections, including peritonitis.

Common side effects of Amivib 500 Injection include high frequency hearing difficulty or ringing in the ears (usually the first sign of ear nerve damage); dizziness (vertigo) or loss of balance; rise in serum creatinine on blood testing; albuminuria and red or white cells and casts in the urine; reduced urine output (oliguria), azotaemia. Get medical help at once if you notice permanent hearing loss or permanent bilateral auditory damage (ototoxicity); kidney damage (toxic nephropathy) or acute renal failure; sudden muscle paralysis or difficulty in breathing after the injection (neuromuscular blockade and apnea).

Amivib 500 Injection contains Amikacin 500 mg. Amivib 500 Injection is given by a doctor or nurse, who decides the dose and how often it is given.

The MRP of Amivib 500 Injection is ₹116.48 for a pack of 1. For chemists and distributors, the PTR is ₹88.75 and the PTS is ₹79.87.

Amivib 500 Injection contains Amikacin 500 mg. It comes in a pack of 1.

Amikacin in this injection attaches itself to the bacteria's ribosome and stops the bacteria from making new protein. Without protein, susceptible bacteria cannot grow or survive and are killed. The antibiotic acts against a range of Gram-negative bacteria.

Must not be used by anyone with a history of allergy (hypersensitivity) to amikacin. Must not be used by anyone with a history of allergy or serious toxic reaction to any aminoglycoside antibiotic, because of known cross-sensitivity within the class. Check with a doctor first if you are pregnant: aminoglycosides cross the placenta and can harm the fetus, and irreversible bilateral deafness has been reported in newborns, so use in pregnancy needs an explicit risk-benefit decision by the doctor. Check with a doctor first if you have kidney damage, hearing problems or balance problems: the risk of ear and kidney damage is greater in these patients and treatment needs close clinical observation. Check with a doctor first if you are sensitive to sulfites: this injection may contain sodium metabisulfite, which can cause allergic-type reactions including anaphylactic symptoms and severe asthmatic episodes; sulfite-sensitive people should avoid exposure.

Amivib 500 Injection is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.